SciSparc Ltd.

6-K 1 ea0306377-6k_scisparc.htm REPORT OF FOREIGN PRIVATE ISSUER

under the Securities Exchange Act of 1934

For the month of September 2026 (Report No. 2)

(Translation of registrant's name into English)

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

On September 23, 2026, SciSparc Ltd. (the "Company") issued a press release titled "SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations." A copy of this press release is furnished herewith as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K (the "Report") and is incorporated by reference herein.

99.1 Press release issued by SciSparc Ltd. titled "SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations."